Editorial: JAK inhibition in autoimmune and inflammatory diseases

Editorial: JAK inhibition in autoimmune and inflammatory diseases

Bibliographic Details
Main Authors:	Jean-Baptiste Telliez, Massimo Gadina, Kamran Ghoreschi, Olli Silvennoinen, Francesca Romana Spinelli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Immunology
Subjects:	autoimmune diseases JAK - STAT signaling pathway JAK STAT (signal transducer and activator of transcription) inflammatory disease
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1120281/full

Similar Items

JAK/STAT in leukemia: a clinical update
by: Dong Liang, et al.
Published: (2024-01-01)

The Hyperactivation of JAK-STAT Signaling Connects Inborn Errors of Immunity and Autoimmune Diseases
by: JIANG Yi, et al.
Published: (2024-10-01)

Phytochemicals Targeting JAK–STAT Pathways in Inflammatory Bowel Disease: Insights from Animal Models
by: Sun Young Moon, et al.
Published: (2021-05-01)

Autoimmune diseases share a common genetic architecture involving the JAK-STAT pathway
by: Iraj Saadat, et al.
Published: (2024-08-01)

JAK/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases
by: Yimeng Dai, et al.
Published: (2025-03-01)

Small molecule drug discovery targeting the JAK-STAT pathway
by: You Lv, et al.
Published: (2024-06-01)

“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
by: Emira Bousoik, et al.
Published: (2018-07-01)

The role of IL‐6/JAK/STAT signal in female infertility caused by hydrosalpinx
by: Jia Deng, et al.
Published: (2023-06-01)

STAT5-Interacting Proteins: A Synopsis of Proteins that Regulate STAT5 Activity
by: Ashley A. Able, et al.
Published: (2017-03-01)

Systemic Treatment of Psoriasis with JAK Inhibitors: A Review
by: Amanda Kvist-Hansen, et al.
Published: (2019-12-01)

SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis
by: Rahul Pandey, et al.
Published: (2023-10-01)

The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients
by: Mei-qi Mao, et al.
Published: (2023-06-01)

JAK-STAT signaling pathway and diabetic complications
by: YU Ziman, ZHAO Bingjia, YANG Dan
Published: (2023-10-01)

The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms
by: Jia Liu, et al.
Published: (2023-01-01)

Cannabidiol Alleviates Imiquimod-Induced Psoriasis by Inhibiting JAK2–STAT3 in a Mouse Model
by: Min-Seo Kim, et al.
Published: (2024-09-01)

Knockdown of miR-155 alleviates skin damage in rats with chronic spontaneous urticaria by modulating the JAK/STAT signaling pathway
by: Yue-peng An, et al.
Published: (2024-06-01)

Janus kinase inhibitors in autoimmune bullous diseases
by: Dawei Huang, et al.
Published: (2023-07-01)

Double-edged sword of JAK/STAT signaling pathway in viral infections: novel insights into virotherapy
by: Mohamad Mahjoor, et al.
Published: (2023-10-01)

Research Advances of JAK/STAT Signaling Pathway in Lung Cancer
by: Xin YANG, et al.
Published: (2019-01-01)

Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies
by: Ethan L. Morgan, et al.
Published: (2020-09-01)

Pain in axial spondyloarthritis: role of the JAK/STAT pathway
by: Carlo Selmi, et al.
Published: (2024-02-01)

Novel association between STAT3 gene variant and vitiligo: A case-control study
by: Vaibhav Venkatesh, et al.
Published: (2022-01-01)

A bacterial effector protein promotes nuclear translocation of Stat3 to induce IL-10
by: Laura Berneking, et al.
Published: (2023-12-01)

Inflammation and JAK/STAT Signaling: New Clues for the Treatment of COVID-19
by: Reza Shirazinia, et al.
Published: (2022-09-01)

Post-transcriptional regulatory feedback encodes JAK-STAT signal memory of interferon stimulation
by: Eirini Kalliara, et al.
Published: (2022-09-01)

Effect of silibinin on GAS6/sAXL and JAK/STAT pathways in human cholangiocarcinoma cell line
by: Caliskan Zehra Nur, et al.
Published: (2024-09-01)

JAK inhibition ameliorated experimental autoimmune encephalomyelitis by blocking GM-CSF-driven inflammatory signature of monocytes
by: Shuai Shao, et al.
Published: (2023-10-01)

JAK/STAT signaling in diabetic kidney disease
by: Yingjun Liu, et al.
Published: (2023-08-01)

Natural products for the treatment of ulcerative colitis: focus on the JAK/STAT pathway
by: Dan Long, et al.
Published: (2025-02-01)

JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
by: I-Hsin Huang, et al.
Published: (2022-12-01)

Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit
by: Xilan Yang, et al.
Published: (2020-03-01)

Protective effect of baicalin on oxidative stress injury in retinal ganglion cells through the JAK/STAT signaling pathway in vitro and in vivo
by: Huan Yu, et al.
Published: (2024-10-01)

JAK/STAT mediated insulin resistance in muscles is essential for effective immune response
by: Ellen McMullen, et al.
Published: (2024-04-01)

Effects of estradiol on the JAK/STAT pathway and the expression levels of inflammatory cytokines in a gonococcal infection model
by: ZHENG Chunchan, et al.
Published: (2024-12-01)

Loganin alleviates LPS‐activated intestinal epithelial inflammation by regulating TLR4/NF‐κB and JAK/STAT3 signaling pathways
by: Jia‐Wen Wang, et al.
Published: (2020-04-01)

Effect of scutellarin on BV-2 microglial-mediated apoptosis in PC12 cells via JAK2/STAT3 signalling pathway
by: Zhao-Da Duan, et al.
Published: (2024-06-01)

Deregulation of PRDM5 promotes cell proliferation by regulating JAK/STAT signaling pathway through SOCS1 in human lung adenocarcinoma
by: Yuanyuan Ren, et al.
Published: (2023-02-01)

Treatment of Atopic Dermatitis Using JAK Inhibitors: A Systematic Review
by: Stefan Siedlikowski, et al.
Published: (2019-11-01)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
by: Maddison Lensing, et al.
Published: (2022-08-01)

Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
by: Izabella Ryguła, et al.
Published: (2023-12-01)